• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,983.18 64.42
( 0.09%)
Global Indices
Nasdaq
50,884.98 77.97
(0.15%)
Dow Jones
7,407.31 -19.42
(-0.26%)
Hang Seng
64,234.22 -1,182.41
(-1.81%)
Nikkei 225
10,254.58 27.25
(0.27%)
Forex
USD-INR
95.53 0.30
(0.32%)
EUR-INR
110.14 0.47
(0.43%)
GBP-INR
127.43 0.45
(0.36%)
JPY-INR
0.60 0.00
(0.41%)

EQUITY - MARKET SCREENER

Titan Company Ltd
Industry :  Diamond Cutting / Jewellery
BSE Code
ISIN Demat
Book Value()
500114
INE280A01028
230.7625365
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TITAN
77.59
364378.51
EPS(TTM)
Face Value()
Div & Yield %
52.9
1
0.37
 

Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13